Stock Forecast

  Photonike Capital SA ( MLPHO.PA) Stock. Should you Buy or Sell?    $ 1.73

-0.07 (-4.22 %)



Photonike Capital SA Analysis

Updated on 10-09-2022
Symbol MLPHO.PA
Price $1.73
Beta 0.000
Volume Avg. $3.86 thousand
Market Cap $32.07 M
52 Week Range $0.805 - $1.8


Photonike Capital SA opened the day at $1.73 which is -4.22 % on yesterday's close. Photonike Capital SA has a 52 week high of $1.8 and 52 week low of $0.805, which is a difference of $0.995. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $32.07 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Photonike Capital SA for $32.07 M, it would take 15 years to get your money back. Photonike Capital SA are in the Capital Markets space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




Photonike Capital SA Stock Forecast - Is Photonike Capital SA a Buy or Sell?


DCF Score
ROE Score
ROA Score
DE Score
PE Score
PB Score
Overall Recommendation

Growth and Value


PE Ratio 0.000
Dividend Yiel 0.000
Net Profit Margin 0.000


Valuing Photonike Capital SA


Price Book Value Ratio 0.000 Price To Book Ratio 0.000
Price To Sales Ratio 0.000 Price Earnings Ratio 0.000


How liquid is Photonike Capital SA


Current Ratio 0.000
Quick Ratio 0.000


Debt


Debt Ratio 0.000 Debt Equity Ratio 0.000
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000



Latest news about Photonike Capital SA






About Photonike Capital SA


CEO : None
Sector : Financial Services
Industry : Capital Markets

Website : https://www.photonike.com

Exchange : Paris

Description :

Photonike Capital SA provides bespoke risk protection solutions in the industrial and financial processes. It offers tailor made solutions for credit enhancement, market hedging, and alternative finance purposes. The company was founded in 2008 and is based in Brussels, Belgium.


My Newsletter

Sign Up For Updates & Newsletters